Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
FAP,Prolyl endopeptidase FAP,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",22080,194,0.69 [0.43-1.08],0.1063608340874933
FAP,Prolyl endopeptidase FAP,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23306,251,0.72 [0.48-1.08],0.1080191525115777
FAP,Prolyl endopeptidase FAP,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23026,1774,0.62 [0.53-0.73],1.1689972999528287e-09
FAP,Prolyl endopeptidase FAP,Chapter I Certain infectious and parasitic diseases,Candidiasis,23311,558,0.71 [0.54-0.94],0.014626524107021
FAP,Prolyl endopeptidase FAP,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,22545,4274,0.69 [0.62-0.76],1.924505249582215e-13
FAP,Prolyl endopeptidase FAP,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),22484,4352,0.69 [0.63-0.76],2.37475576273306e-13
FAP,Prolyl endopeptidase FAP,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,23017,1441,0.62 [0.52-0.74],3.7387567838405296e-08
FAP,Prolyl endopeptidase FAP,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,23215,130,0.51 [0.29-0.89],0.0181326036557474
FAP,Prolyl endopeptidase FAP,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,20452,1314,0.61 [0.51-0.73],5.056443998096834e-08
FAP,Prolyl endopeptidase FAP,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,19732,1599,0.52 [0.44-0.61],7.318639164279019e-16
FAP,Prolyl endopeptidase FAP,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,19226,347,0.71 [0.50-1.01],0.0550926436869051
FAP,Prolyl endopeptidase FAP,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,15156,2778,0.62 [0.55-0.71],7.97454511995598e-14
FAP,Prolyl endopeptidase FAP,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,19165,501,0.47 [0.35-0.62],2.1197125500935814e-07
FAP,Prolyl endopeptidase FAP,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23289,1713,0.67 [0.57-0.78],4.755609900689076e-07
FAP,Prolyl endopeptidase FAP,Chapter I Certain infectious and parasitic diseases,Mycoses,23407,654,0.73 [0.57-0.94],0.0133106262123855
FAP,Prolyl endopeptidase FAP,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22506,1254,0.50 [0.42-0.60],8.584816473861503e-14
FAP,Prolyl endopeptidase FAP,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23334,1448,0.64 [0.54-0.76],2.462008204757257e-07
FAP,Prolyl endopeptidase FAP,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,21827,251,0.69 [0.46-1.04],0.0761270498933599
FAP,Prolyl endopeptidase FAP,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,23468,67,1.42 [0.63-3.17],0.3950921933397794
FAP,Prolyl endopeptidase FAP,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23152,1266,0.65 [0.54-0.78],3.3647170072720074e-06
FAP,Prolyl endopeptidase FAP,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23166,81,1.18 [0.58-2.41],0.6428929087603567
FAP,Prolyl endopeptidase FAP,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23403,143,0.78 [0.46-1.33],0.3665042731833829
FAP,Prolyl endopeptidase FAP,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23380,120,0.89 [0.50-1.61],0.7030322817912791
FAP,Prolyl endopeptidase FAP,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,21762,510,0.88 [0.66-1.17],0.3636086064025374
FAP,Prolyl endopeptidase FAP,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,21566,314,0.66 [0.46-0.95],0.0270640082956853
FAP,Prolyl endopeptidase FAP,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,21715,139,0.57 [0.33-0.98],0.0411910409173114
FAP,Prolyl endopeptidase FAP,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23453,53,0.87 [0.36-2.10],0.7549216270548001
FAP,Prolyl endopeptidase FAP,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23399,173,0.71 [0.44-1.16],0.1752261222777309
FAP,Prolyl endopeptidase FAP,Chapter I Certain infectious and parasitic diseases,Viral warts,23281,55,1.02 [0.42-2.47],0.9655898535633396
FAP,Prolyl endopeptidase FAP,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23305,79,0.50 [0.25-1.02],0.0574832156241504
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,Benign lipomatous neoplasm,23172,269,0.64 [0.44-0.95],0.0262673821779281
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23385,40,1.15 [0.41-3.23],0.7977795398840285
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23366,44,0.92 [0.35-2.39],0.8621116367161015
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,11187,86,0.51 [0.25-1.01],0.0540620357997523
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",22994,1699,0.88 [0.75-1.03],0.1056341616804872
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,Benign neoplasm of meninges,23452,65,0.38 [0.18-0.83],0.0151536998536255
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23371,80,0.59 [0.37-0.92],0.021185414020172
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,23440,121,0.68 [0.38-1.20],0.181420769581447
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,Benign neoplasm of ovary,12212,81,1.00 [0.48-2.08],0.9960125419099296
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,Benign neoplasm: Ascending colon,23428,448,0.84 [0.62-1.14],0.2583838244238376
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,Benign neoplasm: Caecum,23433,391,0.78 [0.56-1.07],0.1257720804402599
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23318,88,0.82 [0.42-1.62],0.5706068372969528
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,Benign neoplasm: Descending colon,23424,257,0.74 [0.50-1.11],0.146110854028652
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,Benign neoplasm: Rectum,23382,411,1.02 [0.74-1.40],0.9225031288332488
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23309,684,0.92 [0.72-1.17],0.4967793719596941
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,Benign neoplasm: Transverse colon,23409,551,1.03 [0.79-1.36],0.80807407546586
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,Carcinoma in situ of breast,9177,49,2.01 [0.78-5.21],0.1510491119610739
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",9221,67,1.25 [0.55-2.81],0.5925724640492678
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",16740,73,1.00 [0.46-2.15],0.995259726281706
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",16768,101,0.33 [0.18-0.62],0.000593557853003
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23411,126,0.86 [0.48-1.54],0.6209777179663389
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,"Haemangioma, any site",23412,123,0.82 [0.46-1.48],0.5168160550396625
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,Leiomyoma of uterus,11938,171,0.98 [0.59-1.61],0.924083445400118
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,Lung cancer and mesothelioma,14844,489,0.36 [0.27-0.48],9.761737905589775e-12
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,Lymphoid leukaemia,16741,74,0.58 [0.27-1.23],0.1538745672040871
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",16893,226,1.02 [0.66-1.59],0.9133284569278068
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",16991,324,0.88 [0.62-1.27],0.503084624751817
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",9300,104,0.81 [0.43-1.55],0.5243024423592102
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",16779,112,1.45 [0.78-2.68],0.2370188983889294
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",16815,148,0.57 [0.34-0.96],0.0350358116054757
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",16791,124,0.87 [0.49-1.56],0.64874802382012
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",9282,86,0.93 [0.45-1.90],0.8369517998106323
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",16795,128,0.80 [0.45-1.43],0.4567004300694709
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",8458,987,1.11 [0.90-1.37],0.3233028465025452
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",16807,140,1.39 [0.79-2.42],0.249161108393324
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",16759,92,1.14 [0.58-2.25],0.7045654043875025
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,16810,143,1.30 [0.74-2.27],0.3601506685322037
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,Melanocytic naevi,23319,187,1.26 [0.78-2.04],0.3485340858866063
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,Melanocytic naevi of trunk,23439,79,2.33 [1.12-4.86],0.024252628476126
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,Melanoma in situ,16720,111,0.56 [0.30-1.04],0.0642935281798167
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",16791,124,0.51 [0.29-0.92],0.0249323833614137
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",16871,204,0.49 [0.31-0.76],0.001759950499925
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",17000,333,0.56 [0.40-0.80],0.0012731174557199
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",16798,131,0.62 [0.35-1.10],0.1028981022676384
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,Other benign neoplasms of skin,23293,166,1.08 [0.66-1.79],0.7517629237343033
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",18181,1514,0.80 [0.68-0.95],0.0117952264179974
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",18265,1598,0.83 [0.70-0.98],0.024671992408891
FAP,Prolyl endopeptidase FAP,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23156,402,0.69 [0.50-0.95],0.0226368389906
FAP,Prolyl endopeptidase FAP,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,21114,165,0.68 [0.41-1.12],0.1296088398712205
FAP,Prolyl endopeptidase FAP,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,22825,71,0.75 [0.35-1.60],0.4528590573871103
FAP,Prolyl endopeptidase FAP,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,22688,3541,0.65 [0.58-0.72],6.130173103499137e-15
FAP,Prolyl endopeptidase FAP,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,21722,74,0.40 [0.19-0.83],0.0139360513141596
FAP,Prolyl endopeptidase FAP,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,22991,64,0.56 [0.26-1.24],0.156011397725987
FAP,Prolyl endopeptidase FAP,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,22946,1997,0.64 [0.56-0.74],1.603331542280693e-09
FAP,Prolyl endopeptidase FAP,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,22944,1995,0.65 [0.56-0.75],2.512411612131381e-09
FAP,Prolyl endopeptidase FAP,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,21066,117,0.71 [0.39-1.29],0.2623046855254777
FAP,Prolyl endopeptidase FAP,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23099,1451,0.56 [0.47-0.66],1.2091066224583459e-11
FAP,Prolyl endopeptidase FAP,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,23039,112,0.78 [0.43-1.42],0.4132633263496852
FAP,Prolyl endopeptidase FAP,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,22829,75,0.88 [0.42-1.85],0.7387238198975459
FAP,Prolyl endopeptidase FAP,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,22831,77,0.64 [0.31-1.32],0.22905343672617
FAP,Prolyl endopeptidase FAP,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23285,358,0.66 [0.47-0.93],0.0165188851904694
FAP,Prolyl endopeptidase FAP,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23335,41,0.85 [0.31-2.34],0.7495343717482299
FAP,Prolyl endopeptidase FAP,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23220,293,0.68 [0.47-0.99],0.0441671796587406
FAP,Prolyl endopeptidase FAP,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,21786,138,0.46 [0.27-0.78],0.0044357070013862
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,15693,423,0.47 [0.35-0.64],1.5705302324705575e-06
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,21937,104,0.69 [0.37-1.31],0.2617491696539635
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,21949,116,0.78 [0.43-1.42],0.4227022882778584
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,15342,72,0.47 [0.22-1.01],0.0519795494252395
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,21794,65,0.50 [0.23-1.09],0.0812866977782487
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,21000,325,0.39 [0.27-0.55],8.968463955681386e-08
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",22655,968,0.63 [0.51-0.77],1.18726782178571e-05
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,22178,491,0.66 [0.49-0.88],0.0054871245686742
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,21909,222,0.49 [0.32-0.76],0.0012760215292685
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23177,1448,0.76 [0.64-0.90],0.001251771215002
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,19741,1404,0.69 [0.58-0.82],3.2471521944119355e-05
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",15364,94,1.27 [0.64-2.50],0.4963780072902131
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",21139,99,1.05 [0.54-2.05],0.8768527858166677
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,15641,371,0.41 [0.30-0.58],1.4268894886139737e-07
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,15327,57,1.96 [0.81-4.75],0.1358117945717525
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,19935,4665,0.87 [0.79-0.95],0.0030943557345306
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,15538,268,0.47 [0.32-0.70],0.0001730425468799
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,15989,719,0.55 [0.43-0.70],8.991962141175159e-07
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23408,376,0.65 [0.47-0.91],0.0108857949227498
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23195,163,0.69 [0.42-1.14],0.1453780831375174
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,15426,156,0.67 [0.40-1.12],0.1279375948939739
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",15352,82,0.32 [0.19-0.52],8.450096935026809e-06
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,22820,1780,0.82 [0.70-0.95],0.0104360117022794
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,15662,392,0.52 [0.38-0.71],4.632231169849996e-05
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,15703,433,0.66 [0.48-0.89],0.0073916761853261
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",16149,879,0.78 [0.63-0.97],0.0251261525722437
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,15448,178,1.12 [0.68-1.83],0.664857616608036
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23185,153,0.74 [0.44-1.24],0.2595434047968565
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,16176,906,0.76 [0.61-0.94],0.0131653109585251
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,15935,665,0.60 [0.47-0.77],6.805348371797916e-05
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,20755,80,1.10 [0.53-2.30],0.7936205072691251
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,21793,6523,0.82 [0.76-0.89],1.297383259143161e-06
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,21101,61,0.55 [0.24-1.25],0.1549555362714109
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,21091,51,1.07 [0.42-2.72],0.8920471507501576
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23279,1936,0.75 [0.65-0.87],0.0001081651987191
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",23277,1934,0.75 [0.65-0.86],7.787440933410655e-05
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,21107,67,0.82 [0.37-1.82],0.6229614096503708
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,23107,1152,0.62 [0.51-0.75],6.278197763767147e-07
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",17538,2268,0.65 [0.57-0.75],5.020413827191352e-10
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23452,319,1.16 [0.82-1.66],0.3981962672932564
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,21821,134,1.05 [0.60-1.84],0.877724797387704
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,22074,119,0.91 [0.50-1.65],0.7524058656038042
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,22121,166,0.82 [0.49-1.35],0.42547239861494
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",15469,199,0.47 [0.30-0.74],0.0011776485014769
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,20625,185,1.27 [0.79-2.04],0.3306910725504993
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2510,102,1.26 [0.70-2.25],0.4380212731039761
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2679,313,1.15 [0.82-1.62],0.4023461221144909
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,20528,88,1.72 [0.88-3.39],0.1131871690611769
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2482,77,1.48 [0.76-2.92],0.2507027749163428
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,22606,2166,1.12 [0.98-1.29],0.0970217884162489
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,22326,639,0.58 [0.45-0.75],2.66720421823872e-05
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,21132,457,0.62 [0.46-0.84],0.0019078305355899
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,16405,1135,0.60 [0.50-0.73],2.63209199025053e-07
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23330,309,0.77 [0.53-1.11],0.1593394900952528
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),21940,274,0.53 [0.36-0.79],0.001548646464628
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Angina pectoris,20265,1598,0.74 [0.63-0.87],0.0002921312241133
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Aortic aneurysm,22045,379,0.60 [0.43-0.83],0.0023268700415576
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,21756,90,0.94 [0.47-1.87],0.8616228127232722
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",21962,296,0.83 [0.57-1.21],0.3388470218769668
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,11869,2887,0.69 [0.61-0.78],7.214552567524738e-09
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,AV-block,17818,688,0.68 [0.53-0.88],0.0026965780332207
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23384,588,0.74 [0.57-0.97],0.0267245709703643
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Cardiac arrest,9253,271,0.56 [0.37-0.85],0.0061306390514965
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Cardiomyopathy,17334,204,0.65 [0.41-1.03],0.0650440641028232
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",17241,111,0.53 [0.28-0.98],0.0418654833081459
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,23463,83,1.32 [0.65-2.67],0.4387739935303261
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Conduction disorders,18713,1583,0.72 [0.61-0.85],9.351672900222632e-05
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,21435,2793,0.80 [0.71-0.91],0.0005371296001011
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,18818,9024,0.89 [0.83-0.96],0.0020283815369705
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,DVT of lower extremities,21868,340,0.74 [0.52-1.06],0.0998009281186321
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Endocarditis,17233,103,0.77 [0.40-1.48],0.4263016071393244
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,"Heart failure, strict",23170,1694,0.62 [0.53-0.73],2.19018670232212e-09
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Hypertension,20075,8033,0.91 [0.85-0.98],0.0138419774910741
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,"Hypertension, essential",20094,8052,0.91 [0.84-0.98],0.0115719375515936
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,"Hypertension, portal",23293,100,6.69 [3.56-12.58],3.573149232189654e-09
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",12310,268,0.79 [0.53-1.17],0.2370316533570699
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,12256,214,0.85 [0.54-1.33],0.4753049282801774
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Hypotension,23282,1668,0.64 [0.54-0.74],1.49382662044358e-08
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,22154,150,0.98 [0.57-1.67],0.9294812343708456
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",21614,2947,0.81 [0.72-0.91],0.0005381242102262
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",22944,811,0.80 [0.64-1.00],0.0546123436900161
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Left bundle-branch block,17664,534,0.76 [0.57-1.01],0.0585424564821981
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,22763,1078,0.77 [0.64-0.94],0.0099872358327486
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",19596,929,0.71 [0.58-0.89],0.0021081081780173
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23337,190,0.71 [0.45-1.13],0.1502055559733309
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",23422,414,0.73 [0.53-1.00],0.047368383408457
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Oesophageal varices,21597,69,3.77 [1.75-8.10],0.0006847553427963
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Other aneurysm,21773,107,0.56 [0.30-1.05],0.0700450050721632
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Other arrhythmias,17737,607,0.62 [0.47-0.80],0.0003716443001569
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,21805,139,0.62 [0.36-1.06],0.0824401741137632
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,22002,336,0.96 [0.67-1.37],0.8199748236809046
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,17358,228,0.73 [0.47-1.12],0.1494629459927518
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Other disorders of veins,21649,121,0.97 [0.54-1.72],0.9046471229627752
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,21575,47,0.58 [0.23-1.47],0.2511827047587814
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,21377,92,1.26 [0.64-2.48],0.4985850921530603
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,21711,183,0.66 [0.41-1.05],0.0810847486588541
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,18616,1486,0.55 [0.46-0.65],2.2306695898466698e-12
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,21677,63,6.44 [2.91-14.24],4.292037828340726e-06
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,22414,748,0.79 [0.63-1.01],0.0553590424133434
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,22685,540,0.59 [0.45-0.77],0.0001412217948124
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",22278,993,0.71 [0.58-0.87],0.0010224250978102
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,9401,419,0.47 [0.34-0.65],7.532861842945549e-06
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Peripheral artery disease,22237,608,0.82 [0.63-1.07],0.1378375806630809
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),21959,431,0.78 [0.57-1.07],0.1204897699852966
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Pulmonary embolism,22754,609,0.89 [0.68-1.15],0.3640145678246863
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23367,986,0.65 [0.53-0.80],3.930738834689475e-05
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Right bundle-branch block,17655,525,0.66 [0.50-0.88],0.0045543163833688
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Secondary right heart disease,22678,533,0.58 [0.44-0.76],9.1833143243758e-05
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,21555,270,0.74 [0.50-1.09],0.1234473032980571
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",22928,924,0.82 [0.66-1.02],0.069130845516248
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",22913,965,0.85 [0.69-1.05],0.1307950180266145
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,22122,64,2.27 [0.99-5.18],0.0526633253823637
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,21773,107,0.91 [0.48-1.72],0.768408213553766
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Transient ischemic attack,22462,329,0.85 [0.59-1.21],0.3603371455583568
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,22025,340,0.75 [0.53-1.06],0.101860759189337
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Varicose veins,22053,525,1.23 [0.92-1.63],0.1614914068350625
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,21686,124,0.40 [0.23-0.71],0.0018557365728729
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23184,963,0.87 [0.71-1.08],0.2051813177555668
FAP,Prolyl endopeptidase FAP,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23383,338,0.74 [0.52-1.04],0.0830076356690578
FAP,Prolyl endopeptidase FAP,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",20041,1403,0.62 [0.52-0.74],1.0641557709747453e-07
FAP,Prolyl endopeptidase FAP,Chapter V Mental and behavioural disorders,Any mental disorder,22924,4286,0.74 [0.67-0.81],1.4968177626529626e-09
FAP,Prolyl endopeptidase FAP,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23354,398,0.77 [0.56-1.07],0.1153997269463626
FAP,Prolyl endopeptidase FAP,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",20114,1476,0.70 [0.59-0.83],3.168698672014576e-05
FAP,Prolyl endopeptidase FAP,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",18724,86,0.81 [0.40-1.65],0.568547573590182
FAP,Prolyl endopeptidase FAP,Chapter V Mental and behavioural disorders,Smoking dependency,22948,1196,0.68 [0.56-0.81],3.435073577784204e-05
FAP,Prolyl endopeptidase FAP,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",20111,1473,0.68 [0.58-0.81],7.917106431468807e-06
FAP,Prolyl endopeptidase FAP,Chapter V Mental and behavioural disorders,Vascular dementia,22548,233,0.61 [0.40-0.94],0.0234345449521332
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Alzheimer disease,23464,603,0.76 [0.58-0.99],0.0396362872120056
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",14359,112,1.00 [0.52-1.90],0.9967909492198932
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Bell's palsy,21584,86,0.79 [0.39-1.58],0.4990298422565792
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22002,504,1.37 [1.03-1.84],0.032803402081734
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Cerebral cysts,23007,253,0.96 [0.64-1.45],0.8487672337493022
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23390,415,0.75 [0.55-1.03],0.0779018420448694
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,22595,77,0.85 [0.40-1.78],0.6588432519287561
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23446,70,1.14 [0.53-2.46],0.7414467400701475
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",22842,88,0.72 [0.36-1.44],0.35230289367715
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Epilepsy,21932,310,1.08 [0.74-1.57],0.6934890597501739
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,22993,1371,0.87 [0.73-1.04],0.1281700419522831
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,23412,940,0.59 [0.48-0.72],6.369029953915187e-07
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Falls/tendency to fall,22792,3498,0.71 [0.64-0.80],2.0635807161888393e-09
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Generalized epilepsy,23076,54,1.44 [0.59-3.52],0.4235057223477476
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Hemiplegia,23315,340,0.80 [0.57-1.14],0.213247085612531
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Hydrocephalus,22828,74,1.45 [0.68-3.13],0.3395040155228187
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23451,72,2.13 [0.98-4.65],0.0575369304859474
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,21566,68,0.56 [0.25-1.22],0.1452609280197954
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,21572,74,0.47 [0.23-0.97],0.0424727483859661
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Memory loss,22293,144,1.39 [0.80-2.40],0.2437375967068008
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Migraine,21904,282,0.99 [0.67-1.47],0.9737256972574184
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23416,259,1.06 [0.71-1.60],0.7650091064334741
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Motor neuron disease,14449,178,1.12 [0.68-1.87],0.6493182874758276
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23332,62,0.42 [0.19-0.94],0.0339007602461355
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22743,1245,1.03 [0.86-1.24],0.7267683461736001
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Neurological diseases,21951,4426,0.83 [0.75-0.92],0.0001989045845966
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,22848,330,0.73 [0.51-1.04],0.0833288526021378
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",21928,430,0.93 [0.68-1.27],0.6336005446363987
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23384,357,1.42 [1.01-2.00],0.0434722873056265
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,17545,996,0.73 [0.59-0.90],0.0033928261500071
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,22844,90,0.95 [0.48-1.87],0.8746034963520855
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Other disorders of nervous system,22918,164,1.89 [1.14-3.14],0.0133311800719792
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,22711,239,0.60 [0.40-0.91],0.0171080506734072
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Other facial nerve disorders,21595,97,1.08 [0.56-2.10],0.8118505538419347
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Other headache syndromes,21675,53,1.08 [0.45-2.64],0.8587054360298869
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Other neurological diseases,23348,594,0.98 [0.75-1.28],0.8860775440521508
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Other sleep disorders,22146,524,0.71 [0.54-0.94],0.0156454770359736
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Parkinson's disease,23433,697,0.55 [0.44-0.71],1.911223482968637e-06
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,22800,46,0.89 [0.34-2.36],0.8186614665539925
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Restless leg syndrome,23465,109,0.69 [0.37-1.28],0.2400976961508648
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Sleep apnoea,23228,444,0.70 [0.52-0.95],0.0199078694972593
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Small fibre neuropathy,23088,61,1.76 [0.75-4.12],0.1942852042850499
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,23453,207,1.08 [0.68-1.71],0.7366758945504358
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,21567,69,1.08 [0.49-2.38],0.8470567782655369
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,23464,609,0.74 [0.57-0.97],0.0283794914706061
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),22485,227,0.62 [0.40-0.95],0.0281888221040447
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,22810,157,0.46 [0.28-0.78],0.0033412698419464
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,22998,569,0.87 [0.66-1.14],0.3097091411134128
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23203,271,1.12 [0.76-1.65],0.5669670289402231
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,22210,70,1.43 [0.65-3.14],0.3780517675768559
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,22178,38,0.58 [0.20-1.65],0.3034201311448293
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23341,74,0.57 [0.27-1.19],0.1320025277497781
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,23140,227,1.04 [0.67-1.60],0.8748223518991862
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2486,78,1.60 [0.81-3.13],0.1733435114323935
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,3072,117,1.61 [0.94-2.77],0.0850494422801752
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,22760,107,0.81 [0.43-1.52],0.5122140232280199
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23158,1449,0.77 [0.65-0.92],0.0033889043568419
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23042,902,0.75 [0.61-0.93],0.0100966596806396
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,22449,309,0.78 [0.54-1.13],0.1911814071188729
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23388,959,0.89 [0.72-1.09],0.2621356320960227
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,23458,82,0.57 [0.28-1.15],0.1157378471216414
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23314,885,0.86 [0.69-1.07],0.1831393090298318
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23421,508,1.01 [0.75-1.35],0.9643803521884092
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23342,230,1.32 [0.86-2.03],0.207074032913058
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,22242,102,0.57 [0.30-1.07],0.0814662368912707
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,22247,107,0.46 [0.25-0.86],0.0143789943240667
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,22217,77,0.73 [0.35-1.54],0.4093067214738315
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23326,1031,1.19 [0.97-1.45],0.1008732297349282
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,22565,270,1.13 [0.76-1.68],0.5470839361446171
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,22502,73,0.67 [0.32-1.42],0.2945150933548364
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,23040,127,1.20 [0.67-2.15],0.5299546057426464
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23308,395,0.99 [0.71-1.38],0.9656709420899878
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,22651,222,0.96 [0.62-1.50],0.8659020504287938
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,23257,145,1.08 [0.63-1.86],0.7793651028773714
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,22984,689,1.26 [0.99-1.62],0.0651282650748907
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,22815,162,0.97 [0.58-1.62],0.9115670760521638
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,20980,3291,0.96 [0.86-1.08],0.5196189437194711
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23262,349,1.05 [0.74-1.49],0.7980918284278029
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23451,193,1.10 [0.69-1.76],0.675931622554817
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,22694,554,0.80 [0.61-1.05],0.1076263243536834
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,23006,93,1.15 [0.59-2.26],0.6848526536839468
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,23449,73,0.61 [0.29-1.29],0.1956387339577595
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,22270,130,1.37 [0.77-2.44],0.2851725837088646
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,22318,178,0.87 [0.53-1.41],0.5638702484970319
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,21876,167,1.00 [0.60-1.67],0.9931203851168324
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,22493,64,1.28 [0.56-2.92],0.5545221678580535
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",21784,75,1.27 [0.59-2.74],0.5390129809706041
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,22412,117,0.79 [0.44-1.45],0.4521362477023475
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",22593,298,1.04 [0.71-1.52],0.8485924872149768
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,22304,164,0.83 [0.50-1.37],0.4645686676674928
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,21806,97,1.02 [0.52-1.99],0.9590596388184056
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,21844,135,1.16 [0.66-2.05],0.5998624243539825
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,20460,2771,0.88 [0.78-1.00],0.0442049356021255
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,22232,92,0.81 [0.41-1.59],0.5350278127778344
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23164,511,0.73 [0.55-0.97],0.0309049717972771
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,22732,79,1.14 [0.55-2.37],0.7246845997086053
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),22865,212,0.59 [0.38-0.92],0.019752741643435
FAP,Prolyl endopeptidase FAP,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,23240,115,0.57 [0.32-1.05],0.0698663007819912
FAP,Prolyl endopeptidase FAP,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23418,141,1.27 [0.74-2.20],0.3835893010373321
FAP,Prolyl endopeptidase FAP,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23325,119,1.09 [0.60-1.98],0.7725943688950416
FAP,Prolyl endopeptidase FAP,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23191,66,0.72 [0.32-1.60],0.4153428748331705
FAP,Prolyl endopeptidase FAP,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,23194,69,1.11 [0.50-2.44],0.8011278180927537
FAP,Prolyl endopeptidase FAP,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23357,1268,0.78 [0.65-0.93],0.0070381559386713
FAP,Prolyl endopeptidase FAP,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,23051,962,0.76 [0.61-0.93],0.0094179460658206
FAP,Prolyl endopeptidase FAP,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,22244,155,0.93 [0.55-1.58],0.798899220223496
FAP,Prolyl endopeptidase FAP,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,22180,91,0.70 [0.36-1.38],0.3010972567023833
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Acute pharyngitis,23270,68,1.05 [0.48-2.31],0.8969992260448442
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23392,190,1.25 [0.78-2.00],0.3504938388092713
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23266,64,1.96 [0.87-4.42],0.1038091616239974
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,All influenza,20737,159,0.46 [0.28-0.76],0.0026523748430472
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),20734,156,0.47 [0.28-0.78],0.0038924511170492
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Allergic asthma (mode),14460,105,0.48 [0.25-0.92],0.0260237528879337
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Allergic rhinitis,23356,240,1.08 [0.70-1.64],0.7370054902857746
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",15692,1734,0.54 [0.46-0.63],1.8535669802430442e-14
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",16067,1712,0.54 [0.46-0.63],3.650139501672675e-14
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),22935,181,0.51 [0.32-0.81],0.00450331242239
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",20683,105,0.35 [0.19-0.65],0.0007547448970625
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Bronchiectasis,19673,527,0.37 [0.28-0.49],1.8550304401437345e-12
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",19221,75,0.45 [0.28-0.74],0.0017718169620348
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,22315,3169,0.58 [0.52-0.65],2.5742288721229662e-20
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",22228,73,1.33 [0.62-2.89],0.4651429806776015
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Chronic sinusitis,22292,137,0.89 [0.51-1.54],0.6689248113523594
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23168,1654,0.47 [0.41-0.55],7.412984324627217e-21
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Deviated nasal septum,22235,80,0.73 [0.35-1.50],0.3893870786047957
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,21279,6191,0.67 [0.61-0.73],6.141818862016573e-21
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22496,341,0.72 [0.51-1.03],0.0689115334453022
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Early onset COPD,21624,110,0.53 [0.29-0.96],0.0368970233932268
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Emphysema,19589,443,0.40 [0.30-0.54],2.736676174930718e-09
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22139,461,0.50 [0.37-0.67],4.677954087703581e-06
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23204,2626,0.59 [0.52-0.66],4.736369997029402e-17
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Interstitial lung disease,22184,506,0.57 [0.43-0.76],0.0001311642266515
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Later onset COPD,22934,1544,0.47 [0.40-0.55],3.1437716027602297e-20
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23449,505,0.51 [0.39-0.68],3.3231672371621584e-06
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Nasal polyp,22253,98,1.15 [0.60-2.23],0.6675509652773691
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23176,1324,0.71 [0.60-0.85],0.0001477082791892
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Other diseases of pleura,23167,2726,0.64 [0.57-0.73],2.377364130766689e-12
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,22915,760,0.81 [0.64-1.02],0.0726109907227043
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Other pleural conditions,20510,69,0.37 [0.17-0.80],0.0112663271051565
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23342,605,0.64 [0.49-0.82],0.0005765594651658
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23333,1737,0.60 [0.51-0.70],6.113542081506229e-11
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Pleural effusion,21832,1391,0.64 [0.54-0.76],3.982545644017982e-07
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Pleural plaque,20696,255,0.60 [0.40-0.90],0.0145589665728251
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",22911,2333,0.57 [0.50-0.65],6.151737134304508e-17
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,23339,395,0.50 [0.36-0.68],1.681228578891587e-05
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Pneumothorax,20612,171,0.33 [0.20-0.53],5.353725857317056e-06
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Pollen allergy,23453,204,0.95 [0.60-1.51],0.8397184743328605
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Pulmonary oedema,22832,95,0.87 [0.45-1.66],0.6709560134035653
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Respiratory insufficiency,14425,70,0.43 [0.24-0.75],0.0029167445820936
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23152,1300,0.71 [0.60-0.85],0.0001981423659939
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,22397,242,1.08 [0.71-1.64],0.7297501178199227
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Viral pneumonia,20885,307,0.55 [0.38-0.80],0.001509950298584
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",22945,245,0.66 [0.44-1.00],0.048780564614528
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,7477,122,0.51 [0.28-0.93],0.0276264804886707
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,14864,61,0.80 [0.35-1.83],0.5920552781505872
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Acute appendicitis,23349,129,1.00 [0.56-1.78],0.9978869997488748
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Acute gastritis,16300,107,0.73 [0.39-1.38],0.3293236570474833
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Acute pancreatitis,21391,203,0.60 [0.38-0.93],0.0234232434357045
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Acute peritonitis,22965,110,0.83 [0.45-1.54],0.5633307583739808
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Alcoholic liver disease,22473,66,6.62 [3.05-14.41],1.8438786871064264e-06
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Barrett oesophagus,16710,517,0.71 [0.54-0.95],0.0227449972270211
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",21336,148,0.39 [0.23-0.65],0.0003291680293225
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",23041,148,0.41 [0.24-0.68],0.0005448551196048
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Cholecystitis,21413,225,0.51 [0.34-0.78],0.0019827591382104
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Cholelithiasis,22253,1065,0.71 [0.58-0.86],0.000607514955911
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Chronic gastritis,16546,353,0.80 [0.57-1.14],0.2134267816089232
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Chronic pancreatitis,21243,55,0.79 [0.33-1.89],0.5998649217724414
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",23325,132,4.92 [2.83-8.54],1.483184961601011e-08
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Coeliac disease,21702,128,0.42 [0.24-0.75],0.0031741432557484
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Collagenous colitis,21701,104,1.05 [0.55-2.01],0.8835546984984283
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23346,161,0.52 [0.31-0.85],0.0086623847718167
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Constipation,23175,2166,0.66 [0.57-0.76],4.774366133435014e-09
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Crohn disease,21687,90,0.49 [0.25-0.96],0.0365130419375615
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23112,69,0.57 [0.27-1.23],0.1545782687425048
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Crohn's disease NAS,21679,82,0.70 [0.34-1.42],0.3228008810008411
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Dental caries,22835,189,0.78 [0.49-1.24],0.2931682104682732
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,20258,2595,0.75 [0.66-0.85],5.373328316664503e-06
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Diseases of appendix,23378,158,1.03 [0.61-1.73],0.9153448009960004
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Diseases of liver,23342,935,1.13 [0.91-1.40],0.2582556275152947
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",20856,4663,0.78 [0.71-0.86],2.778421450877607e-07
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23125,479,0.78 [0.58-1.04],0.0923552906416956
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23372,517,0.51 [0.38-0.67],2.015771790520697e-06
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22739,93,1.13 [0.57-2.22],0.7278431503944585
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Diseases of salivary glands,22612,60,0.45 [0.20-1.01],0.0531458911721054
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Diseases of the digestive system,23122,1548,0.67 [0.57-0.78],1.1136646567499466e-06
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Diseases of tongue,22630,96,0.65 [0.34-1.26],0.2056280068770747
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22733,1545,0.66 [0.56-0.78],5.374084272098142e-07
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,18641,3838,0.71 [0.64-0.79],2.1466840096039384e-10
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Duodenal ulcer,16445,252,0.65 [0.43-0.98],0.0391276328121211
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23369,205,0.66 [0.42-1.03],0.0677241991388458
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23426,28,1.10 [0.32-3.82],0.8789029959468895
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,22561,154,3.33 [1.99-5.57],4.647711092824061e-06
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,14913,110,0.42 [0.23-0.78],0.0055280683924403
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Functional dyspepsia,16766,573,0.75 [0.57-0.99],0.0411863048849163
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Gastric ulcer,16628,435,0.63 [0.46-0.86],0.0032216417256212
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,18904,2711,0.75 [0.66-0.85],4.975942752720473e-06
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,16858,665,0.63 [0.49-0.81],0.0003068242767473
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,16927,8330,0.80 [0.74-0.86],9.946438875468527e-10
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,GI-bleeding,22861,1287,0.70 [0.58-0.83],6.916715282282462e-05
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,22691,45,0.46 [0.18-1.15],0.0956014082155733
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,15806,1197,0.74 [0.61-0.89],0.0016728770308474
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",22477,70,9.27 [4.36-19.73],7.450424562798701e-09
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Hernia,21366,3703,0.74 [0.66-0.82],2.089250671378327e-08
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Impacted teeth,23430,26,1.31 [0.36-4.79],0.6788064798922648
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Impaction of intestines,14882,79,0.62 [0.30-1.29],0.2003373053141853
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Inguinal hernia,18785,1122,0.72 [0.59-0.88],0.0009827084063374
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",17789,126,0.50 [0.28-0.89],0.0186624090677699
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,14920,117,0.53 [0.29-0.96],0.0360756278495689
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Intestinal malabsorption,21721,147,0.52 [0.31-0.90],0.0180561602059113
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,15319,516,0.68 [0.51-0.91],0.0092421153706693
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23432,344,1.23 [0.87-1.73],0.2405765005046287
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22388,791,0.85 [0.68-1.07],0.1776906085865797
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22697,1100,0.84 [0.69-1.02],0.0859363874985603
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Oesophageal obstruction,16417,224,0.63 [0.41-0.97],0.0372994955070633
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Oesophagitis,16901,708,0.68 [0.53-0.87],0.001881310902977
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23408,132,0.82 [0.47-1.45],0.5006406965190764
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,17750,87,0.45 [0.23-0.88],0.0190363067417912
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,16197,1394,0.77 [0.64-0.92],0.0032481988811399
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,21554,366,0.46 [0.33-0.65],5.584220178754567e-06
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,21336,148,0.59 [0.35-0.99],0.0470471666326112
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Other diseases of intestine,16770,1967,0.79 [0.68-0.91],0.0013308719475151
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Other diseases of intestines,21110,6307,0.77 [0.71-0.84],9.986884568676674e-10
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22586,208,0.85 [0.54-1.33],0.4716776647072758
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Other diseases of liver,23182,775,1.12 [0.89-1.41],0.3501034024269293
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,16976,783,0.64 [0.50-0.80],0.0001414281657369
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Other diseases of pancreas,21407,219,0.63 [0.41-0.98],0.0389157813491777
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23295,440,0.45 [0.34-0.61],3.000646754653347e-07
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,17302,1109,0.83 [0.68-1.01],0.0586778081753121
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22878,1304,0.70 [0.59-0.84],0.0001032725531985
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22827,181,0.68 [0.42-1.09],0.106497390788168
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,17016,2213,0.62 [0.54-0.71],1.1951317284174826e-11
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),18394,2201,0.70 [0.61-0.80],3.520418317947872e-07
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,22524,117,3.30 [1.82-5.97],8.359563690300476e-05
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22566,969,0.87 [0.71-1.08],0.2043903698808586
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",15258,455,0.70 [0.52-0.95],0.0238772659754933
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23422,32,1.22 [0.38-3.92],0.7373635193511336
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,15431,628,0.66 [0.51-0.86],0.0018255178244494
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",21731,157,0.52 [0.31-0.87],0.0131777707377518
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Recurring oral aphthae,23453,54,0.71 [0.30-1.70],0.4389680253254924
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,22640,105,0.60 [0.32-1.12],0.1111592991925567
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Toxic colitis,21678,81,0.70 [0.34-1.44],0.336079406522161
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,16540,347,0.64 [0.45-0.91],0.0131638581961593
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Ulcerative colitis,21767,170,0.51 [0.32-0.84],0.0079553349736023
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",21732,135,0.61 [0.35-1.07],0.0845175975695647
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Umbilical hernia,17920,257,0.43 [0.29-0.64],2.084308137217519e-05
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,15053,250,0.74 [0.49-1.12],0.1512253706262395
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Ventral hernia,17957,294,0.53 [0.37-0.77],0.0007613772667741
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Volvulus,14897,94,0.65 [0.33-1.29],0.2155074753839235
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,23356,432,0.91 [0.67-1.25],0.5766248104780607
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,23098,67,1.00 [0.45-2.18],0.9914882764183516
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,20863,168,1.14 [0.68-1.92],0.6081405486493935
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22815,839,0.87 [0.70-1.09],0.2266098963687259
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22123,147,1.14 [0.66-1.94],0.6429812282481582
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,21336,641,0.65 [0.51-0.84],0.0011335945973641
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,23115,324,1.03 [0.72-1.47],0.8799000844279571
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23363,572,0.83 [0.63-1.09],0.1775557555250356
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,22840,49,0.51 [0.21-1.26],0.1447248441018432
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,21837,3798,0.80 [0.72-0.89],4.1487447585691896e-05
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23022,450,0.73 [0.54-0.98],0.0370150786603882
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,22886,314,0.72 [0.50-1.03],0.0747183933489908
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23071,1095,0.88 [0.72-1.07],0.1913099937943272
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",23445,62,0.70 [0.31-1.60],0.4011550038991083
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,20752,57,0.49 [0.29-0.81],0.0054608007264984
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22636,64,1.19 [0.54-2.65],0.6658234377612868
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,23101,310,1.11 [0.77-1.61],0.5639581917573786
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,21310,615,0.87 [0.67-1.14],0.307433018338377
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,20787,92,0.72 [0.36-1.43],0.3426533001429631
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23376,96,0.59 [0.31-1.12],0.1093789235841963
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,22221,245,0.84 [0.56-1.26],0.3999235312265211
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23257,226,0.99 [0.64-1.52],0.962061986688282
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,22888,97,0.53 [0.28-1.01],0.0547826386534998
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,20775,80,0.50 [0.24-1.03],0.061873781107743
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,22844,2149,0.75 [0.65-0.86],6.485994470217112e-05
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",21356,661,0.84 [0.65-1.08],0.1783316859541398
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,20791,96,0.67 [0.34-1.32],0.2518279536523951
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23372,341,0.85 [0.60-1.20],0.3583764213218461
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,22868,77,0.72 [0.35-1.49],0.3763196629869997
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23309,278,0.92 [0.62-1.35],0.6592978752603775
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23389,465,0.95 [0.70-1.29],0.7311026269972345
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,20820,125,1.26 [0.70-2.30],0.4415692480988222
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,21041,346,0.89 [0.62-1.27],0.5204770191616434
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23377,453,0.93 [0.68-1.27],0.6373405976223125
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",21037,342,1.17 [0.83-1.67],0.3712813791966702
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,23437,157,0.62 [0.37-1.02],0.0614540223124479
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,19556,83,0.56 [0.28-1.11],0.0954632996162547
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,20672,6538,0.95 [0.88-1.04],0.2635303916889708
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,19242,5108,0.97 [0.88-1.06],0.5090368450892127
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,19525,52,0.69 [0.28-1.66],0.4037723540430732
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,19458,148,2.01 [1.17-3.46],0.0118647230143338
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,19507,197,0.94 [0.59-1.50],0.8002503539649299
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23197,66,1.55 [0.70-3.43],0.2820029108460416
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",19462,152,0.52 [0.31-0.89],0.01643138632706
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,15640,1506,1.23 [1.04-1.47],0.0175262618041314
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23249,250,1.19 [0.79-1.80],0.4062861687533845
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,19904,594,0.92 [0.70-1.21],0.5432114277470639
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,18980,8157,0.91 [0.84-0.98],0.010096697149873
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,20884,124,0.61 [0.34-1.09],0.0967772887567919
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,19657,184,0.64 [0.40-1.03],0.0649274558351949
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,19990,517,1.24 [0.93-1.65],0.1489548132702571
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22510,3200,0.85 [0.75-0.95],0.0045551199372185
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,19787,314,1.29 [0.89-1.87],0.1833707841207857
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,19626,153,0.48 [0.29-0.81],0.0053385292911898
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,19593,120,1.39 [0.76-2.55],0.2854000907378318
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,22701,103,0.44 [0.23-0.83],0.0108552455789871
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,16178,2044,1.07 [0.93-1.24],0.3500312611821127
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,14946,812,0.81 [0.64-1.01],0.0619665847933342
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23366,805,0.77 [0.62-0.96],0.0214024213292415
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,14213,79,1.09 [0.51-2.33],0.8174714456316157
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),14442,308,1.21 [0.82-1.78],0.3333503318455548
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,19741,268,0.98 [0.66-1.46],0.9200138772491716
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,14619,485,1.21 [0.90-1.64],0.2138388585545469
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,19392,82,0.90 [0.43-1.89],0.7880143205920987
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,20005,695,0.81 [0.63-1.04],0.0927614530440262
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,19628,318,0.72 [0.50-1.03],0.0725354575153887
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,14589,455,1.21 [0.89-1.65],0.2272106424771329
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,19545,72,0.36 [0.17-0.76],0.0074123930832265
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",19533,60,0.42 [0.18-0.94],0.0350364664651685
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,20847,87,1.24 [0.63-2.46],0.5317446634162679
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23027,2267,0.61 [0.53-0.70],2.8124313431607066e-12
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,22348,1588,0.54 [0.46-0.64],2.948727020460033e-13
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23290,545,0.56 [0.42-0.73],2.3296921818020003e-05
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,17320,3186,0.85 [0.75-0.95],0.0047450023010663
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,14177,43,1.06 [0.38-2.93],0.910042753194964
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,19581,108,0.89 [0.48-1.67],0.7223104192984476
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,14206,72,1.58 [0.72-3.48],0.2548577368796252
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),14271,137,0.88 [0.49-1.56],0.653703579721981
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,21008,248,0.87 [0.58-1.32],0.5182153292301688
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,21279,519,0.50 [0.38-0.67],2.744616193517046e-06
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23441,115,1.12 [0.61-2.06],0.7217144314412621
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",21334,2024,0.89 [0.77-1.03],0.1335272566768348
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,19552,79,0.91 [0.44-1.91],0.8032362777472254
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),14292,158,0.89 [0.52-1.51],0.6600249814940597
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,20114,804,0.87 [0.69-1.10],0.2548853715260119
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,16349,2215,1.04 [0.90-1.20],0.5830971435803574
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,22728,130,0.37 [0.21-0.64],0.0004307662970968
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23453,64,1.09 [0.49-2.43],0.8326312348005842
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,19552,79,1.86 [0.89-3.89],0.0975184535031908
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",20848,1375,0.72 [0.60-0.85],0.0001631069306162
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,19581,108,0.68 [0.37-1.28],0.2333207513086395
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,16240,2106,0.90 [0.78-1.04],0.1529418732041093
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,20879,119,0.72 [0.39-1.31],0.2776428228118741
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,19511,38,1.27 [0.43-3.79],0.6661047171994274
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,19510,200,0.73 [0.46-1.15],0.1729430923832786
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20168,695,0.66 [0.52-0.84],0.0007849615217538
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23096,498,0.51 [0.38-0.69],7.360140947015927e-06
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,19983,673,1.03 [0.80-1.33],0.7945523717856312
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23305,539,0.55 [0.42-0.72],1.5282229604308497e-05
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23438,70,0.60 [0.37-0.95],0.0292629839764647
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,19642,169,0.95 [0.57-1.57],0.8308004831918965
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,18236,903,0.83 [0.67-1.02],0.0817540483717259
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20129,656,0.86 [0.67-1.11],0.2597796315794459
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],19755,282,1.26 [0.85-1.86],0.2582046380710051
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",14205,71,1.02 [0.46-2.27],0.954465170830888
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,17309,3175,0.86 [0.76-0.96],0.0086898784975112
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,14985,851,0.98 [0.78-1.22],0.8298013728543275
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,22977,379,0.59 [0.42-0.82],0.0018559528335493
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23408,82,1.18 [0.57-2.43],0.6633622290717309
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",20757,71,0.91 [0.43-1.92],0.8016065942807346
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,14199,65,1.07 [0.47-2.42],0.8792944956364835
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,19420,110,0.66 [0.36-1.24],0.195496189555383
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,14687,553,0.55 [0.42-0.73],2.896348517980798e-05
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,19815,342,1.10 [0.77-1.56],0.6133357057466167
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,19604,294,0.75 [0.51-1.09],0.13307203407965
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,19581,271,0.83 [0.55-1.23],0.3491807941870936
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,16466,68,0.75 [0.34-1.68],0.488792196855386
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23443,75,0.34 [0.17-0.69],0.0029724303235944
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,20035,562,0.97 [0.73-1.27],0.8103125914809531
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],22693,95,0.54 [0.35-0.84],0.0064804355388378
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22157,2684,0.90 [0.80-1.02],0.1061332856890694
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",19624,151,0.44 [0.26-0.73],0.0015717855777521
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,20037,727,1.09 [0.86-1.39],0.4777490597608864
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,22074,280,0.67 [0.46-0.98],0.0411704691844963
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,19570,260,1.29 [0.85-1.94],0.2297648165255179
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,21348,2038,0.81 [0.70-0.93],0.0032460213614461
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,20639,1329,0.84 [0.70-1.00],0.0523630267244396
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],19537,64,2.55 [1.12-5.82],0.025797264998491
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,22718,120,0.36 [0.20-0.64],0.0004515902430869
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,19637,164,1.21 [0.72-2.02],0.4665241450024706
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,19565,92,0.52 [0.27-1.02],0.0570546824758271
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),14212,78,1.17 [0.55-2.50],0.680734052858355
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Acute renal failure,21924,2288,0.62 [0.54-0.71],3.648122051320384e-12
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9394,26,1.78 [0.48-6.66],0.3915466698831807
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,11919,34,1.46 [0.46-4.63],0.5157270443587542
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23131,318,0.82 [0.57-1.17],0.2746658877673558
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,22919,106,0.83 [0.45-1.55],0.5671032516717212
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,22008,2372,0.70 [0.61-0.80],8.242062211386133e-08
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,23225,133,0.87 [0.50-1.49],0.6042360182263606
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,23148,413,0.52 [0.38-0.70],3.249917118823205e-05
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Cystitis,19551,305,0.69 [0.48-1.01],0.0559597155564207
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Dialysis,19735,99,1.02 [0.54-1.95],0.946031569968553
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,10341,2174,0.82 [0.72-0.95],0.0068544295307191
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Disorders of breast,12020,135,0.89 [0.51-1.55],0.6697617797929294
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Endometriosis,9408,40,1.46 [0.51-4.19],0.4823206727253533
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,9955,587,0.75 [0.57-0.98],0.035870438445915
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,19322,6386,0.77 [0.71-0.84],8.459657435726428e-10
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,23191,99,0.96 [0.51-1.79],0.888697463978341
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Hydrocele,8285,118,0.91 [0.50-1.65],0.7527228113287552
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,19709,357,0.68 [0.48-0.96],0.0265273160650834
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,10024,1857,0.77 [0.66-0.89],0.0006223015104281
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,12082,161,0.82 [0.49-1.37],0.4489467354774417
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),8295,128,0.94 [0.53-1.68],0.8326244778200838
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,19335,89,0.68 [0.34-1.35],0.2654330818868529
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,10414,1046,0.74 [0.60-0.91],0.0035372084559908
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,8229,62,0.69 [0.30-1.56],0.367840543816317
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,9408,40,0.38 [0.14-1.02],0.0535965805746697
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",23450,90,0.82 [0.42-1.63],0.5802308203720519
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",23451,86,0.93 [0.47-1.87],0.8469287773943183
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,22241,2995,0.75 [0.67-0.85],2.1963190137311604e-06
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,20206,960,0.67 [0.54-0.83],0.0002196640779099
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,11935,50,1.05 [0.42-2.61],0.9181045224657112
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23376,641,0.55 [0.43-0.70],2.475593913675564e-06
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,8322,155,0.74 [0.44-1.24],0.2485125209078889
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,8329,162,0.76 [0.46-1.26],0.2847459347916544
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,8321,154,1.07 [0.63-1.82],0.7952242307487529
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,23422,89,0.81 [0.41-1.61],0.5487875197647374
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,21625,2379,0.74 [0.64-0.84],5.94308350600912e-06
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,12003,82,0.83 [0.41-1.71],0.619021456968756
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9437,69,0.57 [0.26-1.25],0.1573518999170267
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",9513,145,0.56 [0.33-0.96],0.0357246078824062
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9421,53,1.06 [0.42-2.67],0.909657461073115
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9469,101,0.68 [0.35-1.32],0.2532310037982446
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,19772,420,0.68 [0.49-0.93],0.0165354637680426
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,22940,205,0.52 [0.33-0.81],0.0039809249411597
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,9493,125,0.86 [0.48-1.56],0.6180544105324159
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,9393,25,0.55 [0.25-1.18],0.1230151176488002
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,9584,216,0.89 [0.57-1.39],0.6174719848462142
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,9462,94,0.77 [0.39-1.52],0.444545677398437
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,9577,209,0.69 [0.44-1.08],0.1085959582448575
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,23140,48,0.92 [0.37-2.33],0.8658544801207355
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",8323,156,0.96 [0.57-1.61],0.8709583639659542
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,23169,3817,0.69 [0.62-0.77],4.303251648382255e-12
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",19446,94,0.81 [0.41-1.59],0.5348956860555241
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,19821,185,0.97 [0.60-1.56],0.8923200775384184
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,22853,40,0.90 [0.34-2.43],0.8402194692283056
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Urethral stricture,19518,272,0.99 [0.67-1.48],0.9745645551878184
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23217,404,0.85 [0.62-1.17],0.3130492895114714
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Uterine polyps,9405,37,0.67 [0.24-1.90],0.4553579327113525
